Human teratocarcinoma cells express functional insulin-like growth factor I receptors

Exp Cell Res. 1989 Oct;184(2):427-39. doi: 10.1016/0014-4827(89)90341-8.

Abstract

Using iodinated insulin-like growth factors (IGFs) we have detected receptors for IGF-I at the cell surface of the clonally derived human embryonal carcinoma cell line Tera 2 clone 13. Affinity crosslinking of IGFs to Tera 2 clone 13-derived membrane preparations revealed the presence of proteins with features of both type-I and type-II IGF receptors. Treatment of Tera 2 clone 13 cells with retinoic acid to induce differentiation results in an increased number of cell surface receptors, apparently without altering the ratio of type-I and type-II receptors. In addition, Tera 2 clone 13 IGF-I receptors catalyze (auto)phosphorylation at tyrosine upon IGF-I and insulin binding. These findings suggest that type-I IGF receptors might be involved in mediating the effects of IGFs and insulin upon the proliferation of Tera 2 clone 13 cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line
  • Cell Membrane / metabolism
  • Cell Membrane / ultrastructure
  • Cell Transformation, Neoplastic / drug effects
  • Gene Expression
  • Humans
  • Insulin / pharmacology
  • Insulin-Like Growth Factor I / pharmacology
  • Insulin-Like Growth Factor II / pharmacology
  • Neoplasms, Germ Cell and Embryonal / metabolism
  • Neoplasms, Germ Cell and Embryonal / pathology
  • Neoplasms, Germ Cell and Embryonal / ultrastructure*
  • Phosphotransferases / metabolism
  • Receptors, Cell Surface / genetics
  • Receptors, Cell Surface / physiology*
  • Receptors, Somatomedin
  • Teratoma / metabolism
  • Teratoma / pathology
  • Teratoma / ultrastructure*
  • Tretinoin / pharmacology
  • Tumor Cells, Cultured / metabolism
  • Tumor Cells, Cultured / pathology

Substances

  • Insulin
  • Receptors, Cell Surface
  • Receptors, Somatomedin
  • Tretinoin
  • Insulin-Like Growth Factor I
  • Insulin-Like Growth Factor II
  • Phosphotransferases